Hedge Funds Are Crazy About Neuroderm Ltd (NDRM)

Now, some big names have jumped into Neuroderm Ltd (NASDAQ:NDRM) headfirst. Adage Capital Management, led by Phill Gross and Robert Atchinson, created the most outsized position in Neuroderm Ltd (NASDAQ:NDRM). Adage Capital Management had $5.1 million invested in the company at the end of the quarter. Ken Greenberg and David Kim’s Ghost Tree Capital also made a $2.4 million investment in the stock during the quarter. The only other fund with a brand new NDRM position is Ori Hershkovitz’s Nexthera Capital.

Let’s also examine hedge fund activity in other stocks similar to Neuroderm Ltd (NASDAQ:NDRM). These stocks are Ares Commercial Real Estate Corp (NYSE:ACRE), Bank Mutual Corporation (NASDAQ:BKMU), Bellicum Pharmaceuticals Inc (NASDAQ:BLCM), and Mechel OAO (ADR) (NYSE:MTL). This group of stocks’ market values are similar to NDRM’s market value.

As you can see these stocks had an average of 6 hedge funds with bullish positions and the average amount invested in these stocks was $33 million. That figure was $121 million in NDRM’s case. Ares Commercial Real Estate Corp (NYSE:ACRE) is the most popular stock in this table. On the other hand Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) is the least popular one with only 3 bullish hedge fund positions. Compared to these stocks Neuroderm Ltd (NASDAQ:NDRM) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers, it may be a good idea to analyze it in detail and potentially include it in your portfolio.

Disclosure: None